RA CAPITAL MANAGEMENT, L.P. reported 1 transaction at PRELUDE THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 4/28/2026ACC: 0001231919-26-000422
10% Owner
Since Apr 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.41M acquired · 1.41M disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−1.41M
Price / share
—
Trade value
—
% of position
17.8%
4/27/2026
7.88M→6.48M
Total
Net shares
−1.41M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/27/2026 | J · J | −1.41M | — | — | 17.8% | 7.88M | 6.48M |
| Total | −1.41M | $0.00 | ||||||
Derivative Transactions1
Pre-Funded Warrants (Right to Buy)
Indirect
Converts to
Common Stock
1.41M shares
Shares
+1.41M
Strike price
0.0001
Held after
1.41M
Exercisable
—
4/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Pre-Funded Warrants (Right to Buy) Indirect | Common Stock1.41M shares | 4/27/2026 | J · J | +1.41M | 0.0001 | — | 1.41M |